Avita Medical targets $3.5B TAM with expanded portfolio amid Cohealyx launch in 2025
Q4 2024 Management View CEO Jim Corbett highlighted the company's transformation into a multiproduct therapeutic acute wound care leader. The product portfolio now includes RECELL, RECELL GO, RECELL ...
Key molecular targets for wound healing identified
The results revealed several critical differences in gene activity between acute and chronic wounds. Key wound ...
AVITA Medical to Host Investor Webinar Briefing
To register for the presentation, please follow this Zoom link: https://us02web.zoom.us/webinar/register/WN_Nx3kCIIOSmOj686nctwpRA. A replay will be available on the AVITA Medical website, ...
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
On February 13, 2025, amended the credit agreement with OrbiMed, adjusting the trailing 12-month revenue covenants for upcoming quarters starting from March 31, 2025, through March 31, 2026; the $115 ...
GP magazine23d
Promotional feature: Guidelines for the treatment of acute minor skin wounds
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
McKnight's Long-Term Care News7d
Pros: Classify post-surgical wound sites
Experts from across healthcare disciplines began working in December on a new classification system for evaluating surgical site wounds.
Taiwan News25d
Wound Management Devices Market A New Frontier Audience Odyssey and the Quest for Market Identification
Wounds are one of the most common afflictions that affect billions of people worldwide. Wounds can be classified into acute and chronic based on the severity. Acute wounds are often recovered by ...